AI reveals insights into link between CD33 and cognitive impairment in Alzheimer's Disease.
Modeling biological mechanisms is a key for disease understanding and drug-target identification. However, formulating quantitative models in the field of Alzheimer's Disease is challenged by a lack of detailed knowledge of relevant biochemical processes. Additionally, fitting differential equa...
Main Authors: | Tamara Raschka, Meemansa Sood, Bruce Schultz, Aybuge Altay, Christian Ebeling, Holger Fröhlich |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-02-01
|
Series: | PLoS Computational Biology |
Online Access: | https://doi.org/10.1371/journal.pcbi.1009894 |
Similar Items
-
Variational Autoencoder Modular Bayesian Networks for Simulation of Heterogeneous Clinical Study Data
by: Luise Gootjes-Dreesbach, et al.
Published: (2020-05-01) -
Generation of realistic synthetic data using Multimodal Neural Ordinary Differential Equations
by: Philipp Wendland, et al.
Published: (2022-08-01) -
A machine learning method for the identification and characterization of novel COVID-19 drug targets
by: Bruce Schultz, et al.
Published: (2023-05-01) -
Advanced AI techniques for classifying Alzheimer’s disease and mild cognitive impairment
by: Sophie Tascedda, et al.
Published: (2024-11-01) -
Alzheimer’s Disease-Associated Alternative Splicing of <i>CD33</i> Is Regulated by the HNRNPA Family Proteins
by: Riho Komuro, et al.
Published: (2023-02-01)